Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenDo renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesEffect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab.Clinical Outcomes of Wulingsan Subtraction Decoction Treatment of Postoperative Brain Edema and Fever as a Complication of Glioma Neurosurgery.Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.
P2860
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
@en
type
label
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
@en
prefLabel
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
@en
P2093
P2860
P356
P1476
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma.
@en
P2093
A Alkhafaji
A F Carpentier
A Marantidou
C Levy-Piedbois
P2860
P304
P356
10.1111/ENE.12746
P577
2015-06-04T00:00:00Z